Plaque brachytherapy in iris and iridociliary melanoma: a systematic review of efficacy and complications
CONCLUSIONS: For brachytherapy of iris and iridociliary melanoma, in a range of 84 to 150 Gy, an increase in radiation dose may increase the risk of complications, while the tumor control rate does not change.PMID:34025736 | PMC:PMC8117704 | DOI:10.5114/jcb.2021.103586
Source: Journal of Contemporary Brachytherapy - Category: Cancer & Oncology Authors: Saeed Karimi Amir Arabi Toktam Shahraki Source Type: research
More News: Brachytherapy | Cancer & Oncology | Cataracts | Databases & Libraries | Eye Cancers | Glaucoma | Iodine | Melanoma | Middle East Health | Skin Cancer | Study | Uveal Melanoma